Tailored Treatment of Permanent Atrial Fibrillation
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and efficacy of the Medtronic Cardiac
Ablation System compared to medical therapy in the persistent and long-standing persistent
atrial fibrillation population.
Phase:
Phase 3
Details
Lead Sponsor:
Medtronic Atrial Fibrillation Solutions Medtronic Cardiac Rhythm and Heart Failure